InsidersTradesSigma
Browse the complete record of transactions filed by Fox Jennifer Lynne, Cadre supérieur. Insider active across 1 companies, notably Emergent BioSolutions Inc.. Aggregated, 1 disclosures have been recorded. The latest transaction was filed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Jennifer Lynne Fox serves as Executive Vice President, General Counsel, and Corporate Secretary at Emergent BioSolutions Inc. She is responsible for overseeing the company's legal affairs and compliance while playing a key role in managing stakeholder relationships. Her expertise contributes to the overall strategy of the company.